Original BioMedicals Has Received a Notification of Approval for the Korean Patent Titled "Composition for Upper Respiratory Tract Drug Delivery and Its Administration Method."
Important News
Our company has received notification from the patent firm that the Korean Patent Certificate for “Composition for Upper Respiratory Tract Drug Delivery and Its Administration Method” has been granted, under Application No. 10-2022-0140542.
Composition and Administration Method for Upper Respiratory Drug Delivery (OBM-B01), Developed by Original BioMedicals, Has Been Approved by TFDA for Phase I Clinical Trials
